ABL Diagnostics Advances Platform-Agnostic NGS Strategy Through DeepChek® Verification on Element Biosciences’ AVITI™

Ongoing verification study supports compatibility of DeepChek® with the AVITI™ platform. Expands opportunities in ...
GEN

Element Biosciences’ NGS Tech, App Stories to Be Featured at ASHG

Element Biosciences, the developer of the AVITI benchtop sequencer, will be sharing details about its technology and discussing customer stories at the annual meeting of the American Society of Human ...
Business Insider

QIAGEN and Element Biosciences partner to offer complete next-generation sequencing workflows for the AVITI System

VENLO, Netherlands, and SAN DIEGO, Nov. 2, 2023 /PRNewswire/ -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and Element Biosciences, Inc. today announced a strategic partnership to offer ...
The Scientist

ABC Sequencing Helps Scientists Get Back to Basics

While next generation sequencing (NGS) has become a staple method for some researchers, it is often out of reach due to its high cost and technical challenges. To solve this problem, a novel ...